Matrix metalloproteinases in stem cell regulation and cancer

Matrix Biology

Volumn 44-46, Issue , 2015, Pages 184-190

  Kessenbrock, Kai ^a   Wang, Chih Yang ^a,b   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cancer; Cell differentiation; Hemopexin domain; Invasion; Stem cell niche

Indexed keywords

COLLAGENASE 3; GELATINASE B; HEMOPEXIN; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3;

CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR CELL; ENZYMOLOGY; GENETICS; METABOLISM; MORPHOGENESIS; NEOPLASM; PATHOLOGY; PHYSIOLOGY; STEM CELL; TUMOR INVASION;

AMPHIBIA;

EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; MORPHOGENESIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; STEM CELL NICHE; STEM CELLS;

EID: 84930763579     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.01.022     Document Type: Review

References (47)

1. Gross J., Lapiere C.M. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 1962, 48:1014-1022.
2. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
3. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
4. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
5. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
6. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
7. Nishida C., Kusubata K., Tashiro Y., Gritli I., Sato A., Ohki-Koizumi M., et al. MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells. Blood 2012, 119:5405-5416.
8. Wang X., Page-McCaw A. A matrix metalloproteinase mediates long-distance attenuation of stem cell proliferation. J Cell Biol 2014, 206:923-936.
9. Muffler S., Stark H.J., Amoros M., Falkowska-Hansen B., Boehnke K., Buhring H.J., et al. A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures. Stem Cells 2008, 26:2506-2515.
10. Kessenbrock K., Dijkgraaf G.J., Lawson D.A., Littlepage L.E., Shahi P., Pieper U., et al. A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. Cell Stem Cell 2013, 13:300-313.
11. Regala R.P., Justilien V., Walsh M.P., Weems C., Khoor A., Murray N.R., et al. Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. PLoS ONE 2011, 6:e26439.
12. Chun T.H., Hotary K.B., Sabeh F., Saltiel A.R., Allen E.D., Weiss S.J. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 2006, 125:577-591.
13. Lu C., Li X.Y., Hu Y., Rowe R.G., Weiss S.J. MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. Blood 2010, 115:221-229.
14. Sawey E.T., Johnson J.A., Crawford H.C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc Natl Acad Sci U S A 2007, 104:19327-19332.
15. Scotti M.L., Smith K.E., Butler A.M., Calcagno S.R., Crawford H.C., Leitges M., et al. Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia. PLoS ONE 2012, 7:e30509.
16. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
17. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176.
18. Ardi V.C., Kupriyanova T.A., Deryugina E.I., Quigley J.P. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A 2007, 104:20262-20267.
19. Mu D., Cambier S., Fjellbirkeland L., Baron J.L., Munger J.S., Kawakatsu H., et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 2002, 157:493-507.
20. Ewald A.J., Brenot A., Duong M., Chan B.S., Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 2008, 14:570-581.
21. Sabeh F., Ota I., Holmbeck K., Birkedal-Hansen H., Soloway P., Balbin M., et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004, 167:769-781.
22. Wolf K., Wu Y.I., Liu Y., Geiger J., Tam E., Overall C., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007, 9:893-904.
23. Friedl P., Wolf K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res 2008, 68:7247-7249.
24. Friedl P., Wolf K. Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev 2009, 28:129-135.
25. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005, 120:303-313.
26. Trivedi V., Boire A., Tchernychev B., Kaneider N.C., Leger A.J., O'Callaghan K., et al. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 2009, 137:332-343.
27. Juncker-Jensen A., Deryugina E.I., Rimann I., Zajac E., Kupriyanova T.A., Engelholm L.H., et al. Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination. Cancer Res 2013, 73:4196-4211.
28. Peng C.H., Liao C.T., Peng S.C., Chen Y.J., Cheng A.J., Juang J.L., et al. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS ONE 2011, 6:e23452.
29. Notterman D.A., Alon U., Sierk A.J., Levine A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001, 61:3124-3130.
30. Nindl I., Dang C., Forschner T., Kuban R.J., Meyer T., Sterry W., et al. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer 2006, 5:30.
31. Skrzypczak M., Goryca K., Rubel T., Paziewska A., Mikula M., Jarosz D., et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS ONE 2010, 5.
32. Ye H., Yu T., Temam S., Ziober B.L., Wang J., Schwartz J.L., et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008, 9:69.
33. Riker A.I., Enkemann S.A., Fodstad O., Liu S., Ren S., Morris C., et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genet 2008, 1:13.
34. Compagno M., Lim W.K., Grunn A., Nandula S.V., Brahmachary M., Shen Q., et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009, 459:717-721.
35. Su H., Hu N., Yang H.H., Wang C., Takikita M., Wang Q.H., et al. Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res 2011, 17:2955-2966.
36. Hou J., Aerts J., den Hamer B., van Ijcken W., den Bakker M., Riegman P., et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS ONE 2010, 5:e10312.
37. Hu N., Clifford R.J., Yang H.H., Wang C., Goldstein A.M., Ding T., et al. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics 2010, 11:576.
38. Hao Y., Triadafilopoulos G., Sahbaie P., Young H.S., Omary M.B., Lowe A.W. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 2006, 131:925-933.
39. Brune V., Tiacci E., Pfeil I., Doring C., Eckerle S., van Noesel C.J., et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 2008, 205:2251-2268.
40. Sanli M., Akar E., Pehlivan S., Bakir K., Tuncozgur B., Isik A.F., et al. The relationship of metalloproteinase gene polymorphisms and lung cancer. J Surg Res 2013, 183:517-523.
41. Liu D., Guo H., Li Y., Xu X., Yang K., Bai Y. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS ONE 2012, 7:e31251.
42. Palavalli L.H., Prickett T.D., Wunderlich J.R., Wei X., Burrell A.S., Porter-Gill P., et al. Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 2009, 41:518-520.
43. Li D., Weber D.R., Deardorff M.A., Hakonarson H., Levine M.A. Exome sequencing reveals a nonsense mutation in MMP13 as a new cause of autosomal recessive metaphyseal anadysplasia. Eur J Hum Genet 2015, 23:264-266.
44. Zhang H., Qi M., Li S., Qi T., Mei H., Huang K., et al. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells. Mol Cancer Ther 2012, 11:1454-1466.
45. Correia A.L., Mori H., Chen E.I., Schmitt F.C., Bissell M.J. The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90beta. Genes Dev 2013, 27:805-817.
46. Remacle A.G., Golubkov V.S., Shiryaev S.A., Dahl R., Stebbins J.L., Chernov A.V., et al. Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth. Cancer Res 2012, 72:2339-2349.
47. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295:2387-2392.